TISSUE REGENIX LIMITED
Get an alert when TISSUE REGENIX LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-05 (in 1y)
Last made up 2026-04-21
Watchouts
Cash
£38K
+58.3% vs 2023
Net assets
-£17M
+2.4% vs 2023
Employees
9
0% vs 2023
Profit before tax
£401K
+112.1% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£2,160,000 | £1,607,000 | |
| Profit before tax | -£3,318,000 | £401,000 | |
| Net profit | -£3,318,000 | £401,000 | |
| Cash | £24,000 | £38,000 | |
| Total assets less current liabilities | -£17,462,000 | £1,826,000 | |
| Net assets | -£17,485,000 | -£17,071,000 | |
| Equity | -£17,485,000 | -£17,071,000 | |
| Average employees | 9 | 9 | |
| Wages | £359,000 | £412,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 12.4% | 88.0% | |
| Gearing (liabilities / total assets) | 140.3% | 139.3% | |
| Current ratio | 0.00x | 0.00x | |
| Interest cover | -1.87x | 1.33x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors are satisfied that Tissue Regenix Group plc is capable of providing the necessary financial support and that the Company, therefore, has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the Directors of the Company continue to adopt the going concern basis in preparing the financial statements.”
Group structure
- TISSUE REGENIX LIMITED · parent
- TRX Wound Care Limited 1%
- TRX Orthopaedics Limited 1%
- TRX Cardiac Limited 1%
- Tissue Regenix Holdings Limited 1%
- Gewebebank Mecklenburg-Vorpommern GmbH ('GBM-V') 0.5%
- Tissue Regenix Wound Care Inc 1%
- Tissue Regenix Orthopedics Inc 1%
- Tissue Regenix Holdings Inc 1%
- CellRight Technologies LLC 1%
Significant events
- “The Directors are not aware of any events that occurred after the reporting date that require reporting.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 23 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LUND, Kirsten Mary | Secretary | 2019-12-20 | — | — |
| LECOQUE, Jay Charles | Director | 2025-09-04 | Nov 1962 | American |
| LUND, Kirsten Mary | Director | 2025-10-16 | Nov 1983 | British |
Show 23 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DEVLIN, Paul John | Secretary | 2017-01-06 | 2018-01-31 |
| JEFFERSON, Ian David | Secretary | 2012-05-02 | 2016-11-21 |
| JONES, Gareth Hywel | Secretary | 2018-10-29 | 2019-12-20 |
| IP2IPO SERVICES LIMITED | Corporate Secretary | 2008-02-15 | 2012-04-22 |
| TECHTRAN LIMITED | Corporate Secretary | 2006-05-05 | 2008-02-15 |
| BARKER, Michael Denis | Director | 2019-08-28 | 2019-11-30 |
| COCKE, David Claiborne | Director | 2021-01-21 | 2025-07-31 |
| COULDWELL, Steven Ashley | Director | 2017-11-02 | 2019-07-31 |
| COVE, Jonathan Howard, Doctor | Director | 2007-08-17 | 2008-02-28 |
| DEVLIN, Paul John | Director | 2017-01-06 | 2018-01-31 |
| DOYLE, Christina, Professor | Director | 2006-08-02 | 2012-12-31 |
| FISHER, John, Professor | Director | 2006-05-05 | 2012-12-31 |
| GLENN, Jonathan Martin | Director | 2020-12-03 | 2025-09-05 |
| INGHAM, Eileen, Professor | Director | 2006-05-05 | 2013-02-28 |
| JEFFERSON, Ian David | Director | 2011-06-13 | 2016-11-21 |
| JONES, Gareth Hywel | Director | 2018-10-29 | 2020-11-24 |
| LEE, Daniel Ray | Director | 2020-11-16 | 2025-10-15 |
| MILLER, Alan Jonathan Richard | Director | 2007-12-20 | 2020-12-03 |
| ODELL, Antony Ruben | Director | 2008-11-10 | 2017-10-31 |
| SAMUEL, John Andrew Walter | Director | 2008-04-11 | 2020-03-19 |
| STEVENSON, Alexander James | Director | 2007-12-20 | 2013-03-08 |
| IP2IPO SERVICES LIMITED | Corporate Director | 2008-02-15 | 2015-04-21 |
| TECHTRAN LIMITED | Corporate Director | 2006-05-05 | 2008-02-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Tissue Regenix Group Plc | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 129 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-07 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-11-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-11 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-11 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-20 | AA | accounts | Accounts with accounts type full | |
| 2025-08-04 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-04-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-28 | AA | accounts | Accounts with accounts type full | |
| 2023-01-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-01-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-09-20 | AA | accounts | Accounts with accounts type full | |
| 2022-05-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-25 | AA | accounts | Accounts with accounts type full | |
| 2021-08-20 | CH01 | officers | Change person director company with change date | |
| 2021-05-25 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+58.3%
£24,000 £38,000
-
Net assets
+2.4%
-£17,485,000 -£17,071,000
-
Employees
0%
9 9
-
Operating profit
+174.4%
-£2,160,000 £1,607,000
-
Profit before tax
+112.1%
-£3,318,000 £401,000
-
Wages
+14.8%
£359,000 £412,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers